UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Michael S. Ryan Inc.

Michael S. Ryan Inc. lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 9.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 827 shares of the healthcare conglomerate’s stock after acquiring an additional 68 shares during the period. Michael S. Ryan Inc.’s holdings in UnitedHealth Group were worth $418,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. M&T Bank Corp grew its position in shares of UnitedHealth Group by 13.4% during the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock worth $128,975,000 after buying an additional 26,074 shares in the last quarter. Benjamin Edwards Inc. raised its stake in shares of UnitedHealth Group by 1,275.3% in the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock valued at $26,060,000 after purchasing an additional 41,308 shares in the last quarter. Parsifal Capital Management LP acquired a new stake in UnitedHealth Group during the third quarter valued at approximately $21,165,000. Discipline Wealth Solutions LLC acquired a new position in shares of UnitedHealth Group in the 3rd quarter worth approximately $558,000. Finally, Franklin Resources Inc. lifted its stake in UnitedHealth Group by 2.5% during the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after purchasing an additional 193,800 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH traded up $9.89 during trading hours on Wednesday, reaching $524.14. 4,057,113 shares of the company’s stock were exchanged, compared to its average volume of 3,934,525. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The business’s 50-day simple moving average is $557.79 and its two-hundred day simple moving average is $561.72. The company has a market capitalization of $482.36 billion, a P/E ratio of 34.15, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the prior year, the business posted $6.56 earnings per share. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.60%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the stock. TD Cowen raised their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Royal Bank of Canada dropped their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Barclays lifted their price objective on shares of UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a research report on Wednesday, November 27th. Finally, KeyCorp started coverage on UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 price target on the stock. Three research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $627.58.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.